{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:48:56Z","timestamp":1761824936395,"version":"build-2065373602"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002657","name":"Istanbul \u00dcniversitesi","doi-asserted-by":"publisher","award":["TYL-2018-30031"],"award-info":[{"award-number":["TYL-2018-30031"]}],"id":[{"id":"10.13039\/501100002657","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["112S483"],"award-info":[{"award-number":["112S483"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Medical Sciences"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.advms.2023.03.003","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T12:42:46Z","timestamp":1681735366000},"page":"169-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Effect of hypoxia on HIF-1\u03b1 and NOS3 expressions in CD34+ cells of JAK2V617F-positive myeloproliferative neoplasms"],"prefix":"10.1016","volume":"68","author":[{"given":"Can Veysel","family":"\u015eoro\u011flu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130ldeniz","family":"Uslu-B\u0131\u00e7ak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selin Fulya","family":"Toprak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akif Selim","family":"Yavuz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sel\u00e7uk","family":"S\u00f6zer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.advms.2023.03.003_bib1","series-title":"Translational approaches in tissue engineering and regenerative medicine","first-page":"49","article-title":"Hematopoietic stem cell and regenerative medicine","author":"Sozer","year":"2007"},{"issue":"12","key":"10.1016\/j.advms.2023.03.003_bib2","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1182\/blood-2016-10-696005","article-title":"Myeloproliferative neoplasm stem cells","volume":"129","author":"Mead","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.advms.2023.03.003_bib3","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1038\/bcj.2011.4","article-title":"Mutations with epigenetic effects in myeloproliferative neoplasms and recent progress in treatment: proceedings from the 5th International Post-ASH Symposium","volume":"1","author":"Tefferi","year":"2011","journal-title":"Blood Cancer J"},{"issue":"1","key":"10.1016\/j.advms.2023.03.003_bib4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13045-021-01116-z","article-title":"Molecular pathogenesis of the myeloproliferative neoplasms","volume":"14","author":"Greenfield","year":"2021","journal-title":"J\u00a0Hematol Oncol"},{"issue":"1","key":"10.1016\/j.advms.2023.03.003_bib5","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1182\/asheducation-2017.1.470","article-title":"Myeloproliferative neoplasms: from origins to outcomes","volume":"2017","author":"Nangalia","year":"2017","journal-title":"Hematology"},{"issue":"1","key":"10.1016\/j.advms.2023.03.003_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3324\/haematol.2014.113845","article-title":"Molecular determinants of pathogenesis and clinical phenotype in myeloproliferative neoplasms","volume":"102","author":"Grinfeld","year":"2017","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.advms.2023.03.003_bib7","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/leu.2010.69","article-title":"Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1","volume":"24","author":"Tefferi","year":"2010","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.advms.2023.03.003_bib8","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.3390\/ijms22095042","article-title":"Recent advances in the use of molecular analyses to inform the diagnosis and prognosis of patients with polycythaemia vera","volume":"22","author":"Stuckey","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.advms.2023.03.003_bib9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/cncr.22365","article-title":"The burden of fatigue and quality of life in myeloproliferative disorders (MPDs): an international Internet-based survey of 1179 MPD patients","volume":"109","author":"Mesa","year":"2007","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.advms.2023.03.003_bib10","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1182\/asheducation-2017.1.470","article-title":"Myeloproliferative neoplasms: from origins to outcomes","volume":"2017","author":"Nangalia","year":"2017","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"5","key":"10.1016\/j.advms.2023.03.003_bib11","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1007\/s12325-020-01314-0","article-title":"The myeloproliferative neoplasm landscape: a patient's eye view","volume":"37","author":"Petruk","year":"2020","journal-title":"Adv Ther"},{"issue":"7","key":"10.1016\/j.advms.2023.03.003_bib12","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/17474086.2021.1944096","article-title":"Improving symptom burden and quality of life in patients with myelofibrosis: current strategies and future directions","volume":"14","author":"Yoon","year":"2021","journal-title":"Expert Rev Hematol"},{"issue":"1035","key":"10.1016\/j.advms.2023.03.003_bib13","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20130676","article-title":"Defining normoxia, physoxia and hypoxia in tumours\u2014implications for treatment response","volume":"87","author":"McKeown","year":"2014","journal-title":"Br J Radiol"},{"key":"10.1016\/j.advms.2023.03.003_bib14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nature12984","article-title":"The bone marrow niche for haematopoietic stem cells","volume":"505","author":"Morrison","year":"2014","journal-title":"Nature"},{"year":"2017","series-title":"Hypoxia in mesenchymal stem cell","author":"Widowati","key":"10.1016\/j.advms.2023.03.003_bib15"},{"key":"10.1016\/j.advms.2023.03.003_bib16","series-title":"Hematopoietik K\u00f6k H\u00fccre: D\u00fcn\u00fc, Bug\u00fcn\u00fc ve Yar\u0131n\u0131","first-page":"69","author":"Tokdemir","year":"2019"},{"issue":"1","key":"10.1016\/j.advms.2023.03.003_bib17","doi-asserted-by":"crossref","DOI":"10.1186\/s13578-015-0020-3","article-title":"Hypoxic metabolism in human hematopoietic stem cells","volume":"5","author":"Kocabas","year":"2015","journal-title":"Cell Biosci"},{"issue":"13","key":"10.1016\/j.advms.2023.03.003_bib18","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.1073\/pnas.0701152104","article-title":"Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia","volume":"104","author":"Parmar","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.advms.2023.03.003_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/cells8020155","article-title":"Hypoxia pathway proteins in normal and malignant hematopoiesis","volume":"8","author":"Wielockx","year":"2019","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.advms.2023.03.003_bib20","doi-asserted-by":"crossref","first-page":"248","DOI":"10.20892\/j.issn.2095-3941.2016.0023","article-title":"Bone marrow niche-mediated survival of leukemia stem cells in acute myeloid leukemia: yin and Yang","volume":"13","author":"Zhou","year":"2016","journal-title":"Cancer Biol Med"},{"issue":"4","key":"10.1016\/j.advms.2023.03.003_bib21","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/carcin\/bgn032","article-title":"Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via AMP-activated protein kinase in DU145 human prostate cancer cells","volume":"29","author":"Jung","year":"2008","journal-title":"Carcinogenesis"},{"issue":"9","key":"10.1016\/j.advms.2023.03.003_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.exphem.2014.05.007","article-title":"Hypoxia inhibits JAK2V617F activation via suppression of SHP-2 function in myeloproliferative neoplasm cells","volume":"42","author":"Mitsumori","year":"2014","journal-title":"Exp Hematol"},{"issue":"12","key":"10.1016\/j.advms.2023.03.003_bib23","first-page":"5447","article-title":"A\u00a0nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation","volume":"12","author":"Semenza","year":"1992","journal-title":"Mol Cell Biol"},{"issue":"6","key":"10.1016\/j.advms.2023.03.003_bib24","doi-asserted-by":"crossref","first-page":"F1287","DOI":"10.1152\/ajprenal.00736.2009","article-title":"Regulated oxygen sensing by protein hydroxylation in renal erythropoietin-producing cells","volume":"298","author":"Wenger","year":"2010","journal-title":"Am J Physiol Ren Physiol"},{"issue":"306","key":"10.1016\/j.advms.2023.03.003_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/stke.3062005re12","article-title":"Integration of oxygen signaling at the consensus HRE","volume":"2005","author":"Wenger","year":"2005","journal-title":"Sci STKE"},{"issue":"33","key":"10.1016\/j.advms.2023.03.003_bib26","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.2174\/138161209789649394","article-title":"The VHL tumor suppressor: master regulator of HIF","volume":"15","author":"Haase","year":"2009","journal-title":"Curr Pharmaceut Des"},{"issue":"36","key":"10.1016\/j.advms.2023.03.003_bib27","doi-asserted-by":"crossref","first-page":"22642","DOI":"10.1074\/jbc.272.36.22642","article-title":"Hypoxia-inducible factor 1\u03b1 (HIF-1\u03b1) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions","volume":"272","author":"Salceda","year":"1997","journal-title":"J\u00a0Biol Chem"},{"issue":"5","key":"10.1016\/j.advms.2023.03.003_bib28","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/jcb.25074","article-title":"Regulation of hypoxia-inducible factor-1a by reactive oxygen species: new developments in an old debate","volume":"116","author":"Movafagh","year":"2015","journal-title":"J\u00a0Cell Biochem"},{"issue":"5","key":"10.1016\/j.advms.2023.03.003_bib29","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/sj.leu.2403332","article-title":"Activation of the HIF pathway in childhood ALL, prognostic implications of VEGF","volume":"18","author":"Wellmann","year":"2004","journal-title":"Leukemia"},{"issue":"23","key":"10.1016\/j.advms.2023.03.003_bib30","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1182\/blood-2015-10-677138","article-title":"Adult hematopoietic stem cells lacking Hif-1alpha self-renew normally","volume":"127","author":"Vukovic","year":"2016","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.advms.2023.03.003_bib31","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.stem.2011.02.006","article-title":"Targeting HIF1alpha eliminates cancer stem cells in hematological malignancies","volume":"8","author":"Wang","year":"2011","journal-title":"Cell Stem Cell"},{"issue":"11","key":"10.1016\/j.advms.2023.03.003_bib32","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1182\/blood-2011-10-387381","article-title":"HIF1\u03b1 is required for survival maintenance of chronic myeloid leukemia stem cells","volume":"119","author":"Zhang","year":"2012","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.advms.2023.03.003_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135463","article-title":"Microarray and proteomic analyses of myeloproliferative neoplasms with a highlight on the mTOR signaling pathway","volume":"10","author":"\u010coki\u0107","year":"2015","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.advms.2023.03.003_bib34","first-page":"669","article-title":"[The effect of Ruxolitinib on the expression of VEGF and HIF-1\u03b1 in leukemia HEL cells]","volume":"47","author":"Xu","year":"2016","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"issue":"4","key":"10.1016\/j.advms.2023.03.003_bib35","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/s41375-019-0629-z","article-title":"Hypoxia-inducible factor 1 (HIF-1) is a new therapeutic target in JAK2V617F-positive myeloproliferative neoplasms","volume":"34","author":"Baumeister","year":"2020","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.advms.2023.03.003_bib36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0014-5793(92)80697-F","article-title":"Molecular cloning and characterization of human endothelial nitric oxide synthase","volume":"307","author":"Marsden","year":"1992","journal-title":"FEBS Lett"},{"key":"10.1016\/j.advms.2023.03.003_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/biom11070982","article-title":"Endothelial dysfunction driven by hypoxia the influence of oxygen deficiency on NO bioavailability","volume":"11","author":"Janaszak-Jasiecka","year":"2021","journal-title":"Biomolecules"},{"issue":"5","key":"10.1016\/j.advms.2023.03.003_bib38","doi-asserted-by":"crossref","first-page":"H1921","DOI":"10.1152\/ajpheart.1994.267.5.H1921","article-title":"Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms","volume":"267","author":"McQuillan","year":"1994","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"10.1016\/j.advms.2023.03.003_bib39","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s11658-016-0017-x","article-title":"Posttranscriptional and transcriptional regulation of endothelial nitric-oxide synthase during hypoxia: the role of microRNAs","volume":"21","author":"Kalinowski","year":"2016","journal-title":"Cell Mol Biol Lett"},{"issue":"3","key":"10.1016\/j.advms.2023.03.003_bib40","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.bcmd.2008.06.008","article-title":"Circulating angiogenic monocyte progenitor cells are reduced in JAK2V617F high allele burden myeloproliferative disorders","volume":"41","author":"Sozer","year":"2008","journal-title":"Blood Cells Mol Dis"},{"issue":"11","key":"10.1016\/j.advms.2023.03.003_bib41","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1182\/blood.V110.11.1537.1537","article-title":"Polymorphisms of NOS3 and FCGR2A genes contribute to thrombotic risk in essential thrombocythemia","volume":"110","author":"Olcaydu","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.advms.2023.03.003_bib42","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/mc.22517","article-title":"Angiogenic factors are increased in circulating granulocytes and CD34+ cells of myeloproliferative neoplasms","volume":"56","author":"Suboti\u010dki","year":"2017","journal-title":"Mol Carcinog"},{"issue":"5","key":"10.1016\/j.advms.2023.03.003_bib43","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.advms.2023.03.003_bib44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4274\/tjh.galenos.2021.2021.0607","article-title":"JAK2V617F-Positive endothelial cells induce apoptosis and release JAK2V617F-positive microparticles","volume":"39","author":"Hekimoglu","year":"2022","journal-title":"Turk J Haematol"},{"key":"10.1016\/j.advms.2023.03.003_bib45","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2147\/HP.S92198","article-title":"Frequently asked questions in hypoxia research","volume":"3","author":"Wenger","year":"2015","journal-title":"Hypoxia (Auckl)"},{"issue":"2","key":"10.1016\/j.advms.2023.03.003_bib46","first-page":"34","article-title":"The effects of exogenous IGF-I and MGF on neural stem cells proliferation in hypoxic environments in vitro","volume":"14","author":"Ayd\u0131ntu\u011f G\u00fcrb\u00fcz","year":"2022","journal-title":"Basic Clin Neurosci"},{"issue":"9","key":"10.1016\/j.advms.2023.03.003_bib47","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1039\/c3lc41334a","article-title":"Microfluidic systems for studying neurotransmitters and neurotransmission","volume":"13","author":"Croushore","year":"2013","journal-title":"Lab Chip"},{"issue":"3","key":"10.1016\/j.advms.2023.03.003_bib48","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.stem.2010.06.020","article-title":"Regulation of the HIF-1alpha level is essential for hematopoietic stem cells","volume":"7","author":"Takubo","year":"2010","journal-title":"Cell Stem Cell"},{"issue":"3","key":"10.1016\/j.advms.2023.03.003_bib49","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1074\/jbc.270.3.1230","article-title":"Purification and characterization of hypoxia-inducible factor 1","volume":"270","author":"Wang","year":"1995","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"10.1016\/j.advms.2023.03.003_bib50","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/jat.3749","article-title":"The use of cobalt chloride as a chemical hypoxia model","volume":"39","author":"Mu\u00f1oz-S\u00e1nchez","year":"2019","journal-title":"J\u00a0Appl Toxicol"},{"issue":"9","key":"10.1016\/j.advms.2023.03.003_bib51","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.exphem.2014.05.007","article-title":"Hypoxia inhibits JAK2V617F activation via suppression of SHP-2 function in myeloproliferative neoplasm cells","volume":"42","author":"Mitsumori","year":"2014","journal-title":"Exp Hematol"},{"issue":"11","key":"10.1016\/j.advms.2023.03.003_bib52","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/leu.2013.102","article-title":"A\u00a0role for reactive oxygen species in JAK2V617F myeloproliferative neoplasm progression","volume":"27","author":"Marty","year":"2013","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.advms.2023.03.003_bib53","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.exphem.2010.07.005","article-title":"Oxidative stress is increased in primary and post\u2212polycythemia vera myelofibrosis","volume":"38","author":"Vener","year":"2010","journal-title":"Exp Hematol"},{"issue":"9","key":"10.1016\/j.advms.2023.03.003_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.exphem.2014.05.007","article-title":"Hypoxia inhibits JAK2V617F activation via suppression of SHP-2 function in myeloproliferative neoplasm cells","volume":"42","author":"Mitsumori","year":"2014","journal-title":"Exp Hematol"},{"issue":"1","key":"10.1016\/j.advms.2023.03.003_bib55","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bbcan.2018.10.006","article-title":"Unraveling the journey of cancer stem cells from origin to metastasis","volume":"1871","author":"Nimmakayala","year":"2019","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"3","key":"10.1016\/j.advms.2023.03.003_bib56","first-page":"177","article-title":"Patterns of hydroxyurea prescription and use in routine clinical management of polycythemia vera: a multicenter chart review study","volume":"37","author":"B\u00fcy\u00fcka\u015f\u0131k","year":"2020","journal-title":"Turk J Haematol"},{"issue":"5","key":"10.1016\/j.advms.2023.03.003_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020219","article-title":"CD34+ cells represent highly functional endothelial progenitor cells in murine bone marrow","volume":"6","author":"Yang","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.advms.2023.03.003_bib58","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1002\/stem.1661","article-title":"Concise review: evidence for CD34 as a common marker for diverse progenitors","volume":"32","author":"Sidney","year":"2014","journal-title":"Stem Cell"},{"issue":"11","key":"10.1016\/j.advms.2023.03.003_bib59","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1073\/pnas.88.11.4651","article-title":"Nitric oxide: an endogenous modulator of leukocyte adhesion","volume":"88","author":"Kubes","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.advms.2023.03.003_bib60","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1172\/JCI114081","article-title":"Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells","volume":"83","author":"Garg","year":"1989","journal-title":"J\u00a0Clin Invest"},{"issue":"7","key":"10.1016\/j.advms.2023.03.003_bib61","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s00424-016-1839-0","article-title":"The eNOS signalosome and its link to endothelial dysfunction","volume":"468","author":"Siragusa","year":"2016","journal-title":"Pfl\u00fcgers Archiv"},{"issue":"13","key":"10.1016\/j.advms.2023.03.003_bib62","doi-asserted-by":"crossref","first-page":"6671","DOI":"10.3390\/ijms22136671","article-title":"VEGF regulation of angiogenic factors via inflammatory signaling in myeloproliferative neoplasms","volume":"22","author":"Suboti\u010dki","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"7","key":"10.1016\/j.advms.2023.03.003_bib63","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1182\/blood-2004-02-0744","article-title":"Erythropoietin and hypoxia stimulate erythropoietin receptor and nitric oxide production by endothelial cells","volume":"104","author":"Beleslin-Cokic","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.advms.2023.03.003_bib64","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1182\/blood-2005-11-4454","article-title":"Hydroxyurea induces the eNOS-cGMP pathway in endothelial cells","volume":"108","author":"Cokic","year":"2006","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.advms.2023.03.003_bib65","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1055\/s-0038-1667015","article-title":"Endothelial cells harbouring the JAK2V617F mutation display pro-adherent and pro-thrombotic features","volume":"118","author":"Guadall","year":"2018","journal-title":"Thromb Haemostasis"},{"issue":"11","key":"10.1016\/j.advms.2023.03.003_bib66","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1038\/leu.2010.193","article-title":"Low bone marrow oxygen tension and hypoxia-inducible factor-1alpha overexpression characterize patients with multiple myeloma: role on the transcriptional and proangiogenic profiles of CD138(+) cells","volume":"24","author":"Colla","year":"2010","journal-title":"Leukemia"},{"issue":"22","key":"10.1016\/j.advms.2023.03.003_bib67","doi-asserted-by":"crossref","first-page":"36832","DOI":"10.18632\/oncotarget.15981","article-title":"The hypoxia signalling pathway in haematological malignancies","volume":"8","author":"Irigoyen","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.advms.2023.03.003_bib68","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.exphem.2010.01.005","article-title":"Hypoxia mediates low cell-cycle activity and increases the proportion of long-term-reconstituting hematopoietic stem cells during in vitro culture","volume":"38","author":"Eliasson","year":"2010","journal-title":"Exp Hematol"},{"issue":"3","key":"10.1016\/j.advms.2023.03.003_bib69","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.stem.2010.07.011","article-title":"The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche","volume":"7","author":"Simsek","year":"2010","journal-title":"Cell Stem Cell"},{"issue":"13","key":"10.1016\/j.advms.2023.03.003_bib70","first-page":"4160","article-title":"During ontogeny primitive (CD34+ CD38\u2212) hematopoietic cells show altered expression of a subset of genes associated with early cytokine and differentiation responses of their adult counterparts","volume":"96","author":"Oh","year":"2000","journal-title":"Blood, The Journal of the American Society of Hematology"}],"container-title":["Advances in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112623000123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112623000123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:44:27Z","timestamp":1761824667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1896112623000123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1896112623000123"],"URL":"https:\/\/doi.org\/10.1016\/j.advms.2023.03.003","relation":{},"ISSN":["1896-1126"],"issn-type":[{"type":"print","value":"1896-1126"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of hypoxia on HIF-1\u03b1 and NOS3 expressions in CD34+ cells of JAK2V617F-positive myeloproliferative neoplasms","name":"articletitle","label":"Article Title"},{"value":"Advances in Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.advms.2023.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Medical University of Bialystok. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}